Cargando…
Unfavourable expression of pharmacologic markers in mucinous colorectal cancer
Patients with mucinous colorectal cancer generally have worse prognoses than those with the nonmucinous variety. The reason for this disparity is unclear, but may result from a differential response to adjuvant chemotherapy. We examined known molecular markers for response to common chemotherapy in...
Autores principales: | Glasgow, S C, Yu, J, Carvalho, L P, Shannon, W D, Fleshman, J W, McLeod, H L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361854/ https://www.ncbi.nlm.nih.gov/pubmed/15655543 http://dx.doi.org/10.1038/sj.bjc.6602330 |
Ejemplares similares
-
RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer
por: Church, R D, et al.
Publicado: (2004) -
Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
por: Thomas, F, et al.
Publicado: (2011) -
Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma
por: Karremann, M, et al.
Publicado: (2013) -
Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
por: Lee, J, et al.
Publicado: (2013) -
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
por: Lee, D-W, et al.
Publicado: (2013)